Virulence Factors and Pathogenicity Mechanisms of Acinetobacter baumannii in Respiratory Infectious Diseases

Yake Yao1, Qi Chen1, Hua Zhou1

  • 1Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China.

PubMed

Insights

Acinetobacter baumannii is a dangerous pathogen causing severe respiratory infections. This review details its antibiotic resistance and virulence, aiding in developing new treatments for Acinetobacter baumannii infections.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Pulmonary Medicine

Background:

  • Acinetobacter baumannii is a significant cause of hospital-acquired and community-acquired infections, particularly ventilator-associated pneumonia.
  • This opportunistic pathogen exhibits high genomic plasticity and possesses numerous virulence factors contributing to its pathogenicity.
  • Despite extensive study of its interaction with pulmonary epithelium, a comprehensive understanding of its overall pathogenic process remains incomplete.

Purpose of the Study:

  • To review current knowledge on antibiotic resistance and virulence factors of Acinetobacter baumannii.
  • To specifically focus on the pathogenic mechanisms employed by Acinetobacter baumannii in respiratory infections.
  • To provide a foundation for developing novel therapeutic strategies targeting immunopathology or intracellular signaling pathways.

Main Methods:

  • Literature review of existing studies on Acinetobacter baumannii.
  • Synthesis of information regarding antibiotic resistance mechanisms.
  • Compilation of data on virulence factors and pathogenic strategies in respiratory infections.

Main Results:

  • Acinetobacter baumannii demonstrates significant antibiotic resistance.
  • Key virulence factors and genomic plasticity contribute to its success as a pathogen.
  • Specific pathogenic mechanisms in respiratory infections are detailed, highlighting its detrimental impact.

Conclusions:

  • Understanding Acinetobacter baumannii pathogenesis is crucial for combating respiratory infections.
  • Further research into immunopathology and intracellular signaling pathways is needed for effective therapy development.
  • Targeting these pathways offers a promising avenue for eliminating Acinetobacter baumannii infections.

Related Concept Videos

Defense Against Bacterial Pathogens01:31

Defense Against Bacterial Pathogens

The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
1.4K
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
240
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
279
Infection01:20

Infection

When a pathogen enters the body and reproduces, it can cause an infection, damage body cells, and cause illness symptoms that eventually lead to disease. Therefore, its prevention requires breaking the chain of infection.
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
8.0K
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
142
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
187